GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » LT-Debt-to-Total-Asset

PharmaRoth Labs (PharmaRoth Labs) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. PharmaRoth Labs's long-term debt to total assests ratio for the quarter that ended in Mar. 2011 was 0.00.

PharmaRoth Labs's long-term debt to total assets ratio stayed the same from Mar. 2010 (0.00) to Mar. 2011 (0.00).


PharmaRoth Labs LT-Debt-to-Total-Asset Historical Data

The historical data trend for PharmaRoth Labs's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs LT-Debt-to-Total-Asset Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
LT-Debt-to-Total-Asset
- - -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaRoth Labs LT-Debt-to-Total-Asset Calculation

PharmaRoth Labs's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2010 is calculated as

LT Debt to Total Assets (A: Jun. 2010 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2010 )/Total Assets (A: Jun. 2010 )
=0.25/0
=

PharmaRoth Labs's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2011 is calculated as

LT Debt to Total Assets (Q: Mar. 2011 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2011 )/Total Assets (Q: Mar. 2011 )
=0/0.095
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaRoth Labs  (GREY:ROTH) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


PharmaRoth Labs LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines